Plandai Biotechnology - Interessante Story! - 500 Beiträge pro Seite
eröffnet am 11.05.12 15:26:09 von
neuester Beitrag 28.01.14 18:57:20 von
neuester Beitrag 28.01.14 18:57:20 von
Beiträge: 12
ID: 1.174.204
ID: 1.174.204
Aufrufe heute: 0
Gesamt: 654
Gesamt: 654
Aktive User: 0
Top-Diskussionen
Titel | letzter Beitrag | Aufrufe |
---|---|---|
02.05.24, 18:44 | 632 | |
01.05.24, 18:36 | 227 | |
gestern 22:59 | 186 | |
gestern 22:26 | 171 | |
gestern 22:11 | 151 | |
heute 03:22 | 144 | |
heute 00:47 | 115 | |
gestern 22:06 | 107 |
Meistdiskutierte Wertpapiere
Platz | vorher | Wertpapier | Kurs | Perf. % | Anzahl | ||
---|---|---|---|---|---|---|---|
1. | 1. | 181,19 | +0,66 | 97 | |||
2. | 2. | 18.058,00 | +0,07 | 78 | |||
3. | 3. | 0,1865 | 0,00 | 43 | |||
4. | 4. | 2.309,49 | +0,30 | 26 | |||
5. | 5. | 0,1535 | 0,00 | 23 | |||
6. | 6. | 0,0775 | 0,00 | 23 | |||
7. | 8. | 38.670,25 | +1,19 | 16 | |||
8. | 9. | 9,7000 | +12,27 | 15 |
Ist irgendjemand sonst in diesem Papier investiert? Wohl noch kaum, ist erst seit Dezember 2011 an der OTC gelistet.
Ich finde die Story sehr gut.
Für diejenigen, welche Plandai als neuer Player vielleicht interessieren könnte:
www.plandaibiotech.com
Gelistet an der OTCB unter dem Kürzel: PLPL
US-Stockboard:
http://investorshub.advfn.com/boards/board.aspx?board_id=6382
(Kein Aufforderung zum Kauf, nur eine Anfrage und als Tip für Interessierte)
Ich finde die Story sehr gut.
Für diejenigen, welche Plandai als neuer Player vielleicht interessieren könnte:
www.plandaibiotech.com
Gelistet an der OTCB unter dem Kürzel: PLPL
US-Stockboard:
http://investorshub.advfn.com/boards/board.aspx?board_id=6382
(Kein Aufforderung zum Kauf, nur eine Anfrage und als Tip für Interessierte)
Ich werde dieses Problem bei WO nie verstehen: In der Vorschau funktionieren die URL-Links, im Thread dann nicht.
Naja, sehen wir mal ob sich überhaupt jemand interessiert.
Naja, sehen wir mal ob sich überhaupt jemand interessiert.
das kommt weil du die links fett gemarkert hast und nicht unter links eingeklammert hast
Antwort auf Beitrag Nr.: 43.155.179 von dannie31 am 11.05.12 21:07:50Noch ein wenig Lesematerial:
Coverage 1
The Plandai Opportunity For Investors
Leading Market Analyst Tobin Smith announces “Strong Buy” on The World’s NEXT $Billion Nutritional Foods Company
“ We initiated coverage on Plandai Biotechnology (PLPL)
with a Strong Buy and $22.50 Long Term Target implying
2300%+ UPSIDE from its current market price.
This is an early notice of a recent buy signal. I invite you
to read my complete report by following the link below.
PLPL trades today around .30. My projected growth
for PLPL shareholders is around $3 over next 12
months…followed by stunning capital gains potential
for long term buy-and-hold investors
The Plandai Biotechnology, Inc.(PLPL) Opportunity For Emerging Growth Investors (Plandai
Logo)
In a nutshell, here is why we so STRONGLY suggest the ground floor opportunity of buying and
HOLDING Plandai (PLPL) shares below 50 cents. If you know me from my decades on cable
news, you know ONE thing about me—I am a STRAIGHT shooter who calls ‘em like I see ‘em
and NOT afraid to take a strong position when I KNOW I’m right.
My equity research firm NBT Equities Research LLC STRONGLY believes Plandai Biotechnology
will become the $Billion Next Big Thing in the nutritional foods industry. Planda has the
innovative technology and NOW the virtually unlimited funding capacity (link to Press release
today on $13 Million Loan Facility from South Africa’s Land Bank) from South Africa’s Land Bank
to build a fully integrated nutritional “Super Food” giant conglomerate STARTING with their
game changing “super food” BioTea (service mark) green tea extract.
Plandai’s incredible value proposition to green tea beverage and nutritional supplement
companies? From their plantation in South Africa to your local bottler, Plandai can deliver
its 600-800% MORE ABSORBABLE BioTea to the $20 billion global tea extract market in 180
countries starting next year.
(show GNC logo, Vitamin Shoppe logo, VitaminWorld.com logo)
Yes…with Plandai’s super food BioTea green tea extract, health conscious consumers the world
over get 6-8 TIMES the “good stuff” out of just ONE serving of a 16 ounce green tea beverage or
nutritional supplement (Picture of 8 Green Tea bottles like Nestea vs. ONE Plandai BioTea (use a
service mark).
Plandai’s unique and patent pending technology PLUS access to South Africa’s Land Bank capital
AND literally hundreds of thousands of tea plantation acres will disrupt the $20 billion a year
green tea industry…without question.
Why?
When health conscious consumers around the world can get 6-8 TIMES as high a dosage of
the “good stuff” from just ONE green tea beverages or nutritional supplement, THAT value
proposition changes the market for green tea based products.
In short, why would ANYONE drink 6-8 bottles of green tea a DAY when you can get ALL that
incredible green tea nutrition out of ONE bottle?
Even more important: Why would ANY green tea bottler or nutritional
supplement maker in the $20 billion global annual market for green
tea extract NOT buy Plandai’s BioTea (service mark) green tea extract
with its 6-8 times HIGHER ABSORBALE DOSAGE of the amazing health
improving active ingredient from green tea when they can buy
this super food BioTea extract AT THE SAME PRICE as the low dose
extracts?
6-8 TIMES the good stuff for your customers…at the SAME prices as the low quality existing
green tea extract…what would YOU DO if you were Coca-Cola, Nestle or Unilever…the global
giants of green tea beverages.
Now—When Was the Last Time YOU Got Into A MAJOR Monster Stock at the ABSOLUTE
Ground Floor?
As an investor, you HAVE to ask yourself these questions: What if you were able to invest in 5
Hour Energy at the beginning? What if you had the chance to invest in Snapple, Arizona Tea,
Jones Soda, Hanson (now Monster) energy drinks…all at their ground floor beginnings?
ALL of these stocks had MONSTER 50-150X runs…with Monster Beverages now a $12 billion
value company that initially went public at $30 MILLION valuation—and was buyable at .12-
15 cents at one time. I think from bottom to current value ground floor investors in Monster
Beverage (used to be Hanson Beverages) are up over 120,000%!
This is how fortunes are made. You identify a disruptively innovative product bringing a new
way of doing things that the market does not have…and at the same time riding a $20 billion
trend (growing at 14% rate) for healthier beverages and nutritional supplement featuring the
incredible health benefits within green tea.
FACT: Tea is the SECOND most consumed beverage in the world…water being first.
Like we said, Plandai’s technology and access to South Africa’s Land Bank capital and hundreds
of thousands of tea plantation acres will disrupt the $20 billion a year green tea industry…there
is NO DOUBT in my mind.
But what exactly ARE the incredible health benefits of daily HIGH dosage levels of green tea?
One of the largest manufacturers of high dosage green tea extract cites extensive research that
points to 12 major health benefits of absorbing LARGE AMOUNTS of green tea “catechins” into
your body every day (Gallate catechins are the “good stuff i.e., the active health enhancing
ingredient in green tea)
1) Anti-oxidative and anti-aging effects
2) Immune system enhancing effects
3) Bad breath prevention and deodorant
4) Anti-microbial effects and cold prevention
5) Controlling high blood sugar levels
6) Probiotic effects
7) Controlling high blood pressure
8) Prevention of tooth decay
9) Controlling cholesterol
10) Weight management
11) Enhances DNA integrity
12) Anti-allergic effect
Investors…what do YOU think will happen to Plandai’s stock value when ALL the green tea
bottlers are presented with their super food BioTea product
…ESPECIALLY if Plandai’s 6X-8X more bioavailable/absorbable BioTea (i.e., 60-80% absorbable
green tea “good stuff” per serving) is priced comparable to the existing LOW absorption green
tea extract in the $20 billion market today (i.e., the GROSSLY INFERIOR green tea extract that
whose “good stuff” is ONLY 2-8% absorbable per serving)?
How many of these huge global green tea bottlers—like Coca Cola's Honest Tea brand or
Nestle’s Green Tea brand or Unilver—will move to lock-up EVERY drop of extract that Plandai
makes? (show pictures of the brands)
How long will the “Big Boys” in the $50 billion retail tea industry wait before ENSURING their
EXCLUSIVE supply of Plandai’s BioTea?
Finally…just how DOES a Fortune 100 company go about locking in exclusive ingredients to
their $multi-billion green tea products?
Yes, you guessed it…and THAT is why we believe so strongly that Plandai Biotechnology is the
NEXT $Billion nutritional product company. At some point Coca Cola or Nestle or Unilever etc.
will HAVE to buy them in our opinion. Otherwise their main competitors will be able to use
Plandai’s BioTea super food extract in THEIR green tea beverages, right?
Look…having the ONLY known extraction process that delivers the 60-80% bioavailability to the
$20 billion a year green tea extract market PLUS the financial partner (in South Africa’s Land
Bank) willing to fund acquisition of enough tea plantations to insure $billions and billions of
BioTea extract production is a HUGE opportunity for shareholders at the present valuation.
It’s our strongest Strong Buy recommendation…with a short term $2.50 target…and long term
$22.50 target or 23X UPSIDE from under .50 price.
2300% UPSIDE from the next $billion nutritional food company.
Final question: What are you waiting for?
BUY some shares NOW at the ground floor and DO NOT MISS this monster life changing
investment opportunity
Coverage 1
The Plandai Opportunity For Investors
Leading Market Analyst Tobin Smith announces “Strong Buy” on The World’s NEXT $Billion Nutritional Foods Company
“ We initiated coverage on Plandai Biotechnology (PLPL)
with a Strong Buy and $22.50 Long Term Target implying
2300%+ UPSIDE from its current market price.
This is an early notice of a recent buy signal. I invite you
to read my complete report by following the link below.
PLPL trades today around .30. My projected growth
for PLPL shareholders is around $3 over next 12
months…followed by stunning capital gains potential
for long term buy-and-hold investors
The Plandai Biotechnology, Inc.(PLPL) Opportunity For Emerging Growth Investors (Plandai
Logo)
In a nutshell, here is why we so STRONGLY suggest the ground floor opportunity of buying and
HOLDING Plandai (PLPL) shares below 50 cents. If you know me from my decades on cable
news, you know ONE thing about me—I am a STRAIGHT shooter who calls ‘em like I see ‘em
and NOT afraid to take a strong position when I KNOW I’m right.
My equity research firm NBT Equities Research LLC STRONGLY believes Plandai Biotechnology
will become the $Billion Next Big Thing in the nutritional foods industry. Planda has the
innovative technology and NOW the virtually unlimited funding capacity (link to Press release
today on $13 Million Loan Facility from South Africa’s Land Bank) from South Africa’s Land Bank
to build a fully integrated nutritional “Super Food” giant conglomerate STARTING with their
game changing “super food” BioTea (service mark) green tea extract.
Plandai’s incredible value proposition to green tea beverage and nutritional supplement
companies? From their plantation in South Africa to your local bottler, Plandai can deliver
its 600-800% MORE ABSORBABLE BioTea to the $20 billion global tea extract market in 180
countries starting next year.
(show GNC logo, Vitamin Shoppe logo, VitaminWorld.com logo)
Yes…with Plandai’s super food BioTea green tea extract, health conscious consumers the world
over get 6-8 TIMES the “good stuff” out of just ONE serving of a 16 ounce green tea beverage or
nutritional supplement (Picture of 8 Green Tea bottles like Nestea vs. ONE Plandai BioTea (use a
service mark).
Plandai’s unique and patent pending technology PLUS access to South Africa’s Land Bank capital
AND literally hundreds of thousands of tea plantation acres will disrupt the $20 billion a year
green tea industry…without question.
Why?
When health conscious consumers around the world can get 6-8 TIMES as high a dosage of
the “good stuff” from just ONE green tea beverages or nutritional supplement, THAT value
proposition changes the market for green tea based products.
In short, why would ANYONE drink 6-8 bottles of green tea a DAY when you can get ALL that
incredible green tea nutrition out of ONE bottle?
Even more important: Why would ANY green tea bottler or nutritional
supplement maker in the $20 billion global annual market for green
tea extract NOT buy Plandai’s BioTea (service mark) green tea extract
with its 6-8 times HIGHER ABSORBALE DOSAGE of the amazing health
improving active ingredient from green tea when they can buy
this super food BioTea extract AT THE SAME PRICE as the low dose
extracts?
6-8 TIMES the good stuff for your customers…at the SAME prices as the low quality existing
green tea extract…what would YOU DO if you were Coca-Cola, Nestle or Unilever…the global
giants of green tea beverages.
Now—When Was the Last Time YOU Got Into A MAJOR Monster Stock at the ABSOLUTE
Ground Floor?
As an investor, you HAVE to ask yourself these questions: What if you were able to invest in 5
Hour Energy at the beginning? What if you had the chance to invest in Snapple, Arizona Tea,
Jones Soda, Hanson (now Monster) energy drinks…all at their ground floor beginnings?
ALL of these stocks had MONSTER 50-150X runs…with Monster Beverages now a $12 billion
value company that initially went public at $30 MILLION valuation—and was buyable at .12-
15 cents at one time. I think from bottom to current value ground floor investors in Monster
Beverage (used to be Hanson Beverages) are up over 120,000%!
This is how fortunes are made. You identify a disruptively innovative product bringing a new
way of doing things that the market does not have…and at the same time riding a $20 billion
trend (growing at 14% rate) for healthier beverages and nutritional supplement featuring the
incredible health benefits within green tea.
FACT: Tea is the SECOND most consumed beverage in the world…water being first.
Like we said, Plandai’s technology and access to South Africa’s Land Bank capital and hundreds
of thousands of tea plantation acres will disrupt the $20 billion a year green tea industry…there
is NO DOUBT in my mind.
But what exactly ARE the incredible health benefits of daily HIGH dosage levels of green tea?
One of the largest manufacturers of high dosage green tea extract cites extensive research that
points to 12 major health benefits of absorbing LARGE AMOUNTS of green tea “catechins” into
your body every day (Gallate catechins are the “good stuff i.e., the active health enhancing
ingredient in green tea)
1) Anti-oxidative and anti-aging effects
2) Immune system enhancing effects
3) Bad breath prevention and deodorant
4) Anti-microbial effects and cold prevention
5) Controlling high blood sugar levels
6) Probiotic effects
7) Controlling high blood pressure
8) Prevention of tooth decay
9) Controlling cholesterol
10) Weight management
11) Enhances DNA integrity
12) Anti-allergic effect
Investors…what do YOU think will happen to Plandai’s stock value when ALL the green tea
bottlers are presented with their super food BioTea product
…ESPECIALLY if Plandai’s 6X-8X more bioavailable/absorbable BioTea (i.e., 60-80% absorbable
green tea “good stuff” per serving) is priced comparable to the existing LOW absorption green
tea extract in the $20 billion market today (i.e., the GROSSLY INFERIOR green tea extract that
whose “good stuff” is ONLY 2-8% absorbable per serving)?
How many of these huge global green tea bottlers—like Coca Cola's Honest Tea brand or
Nestle’s Green Tea brand or Unilver—will move to lock-up EVERY drop of extract that Plandai
makes? (show pictures of the brands)
How long will the “Big Boys” in the $50 billion retail tea industry wait before ENSURING their
EXCLUSIVE supply of Plandai’s BioTea?
Finally…just how DOES a Fortune 100 company go about locking in exclusive ingredients to
their $multi-billion green tea products?
Yes, you guessed it…and THAT is why we believe so strongly that Plandai Biotechnology is the
NEXT $Billion nutritional product company. At some point Coca Cola or Nestle or Unilever etc.
will HAVE to buy them in our opinion. Otherwise their main competitors will be able to use
Plandai’s BioTea super food extract in THEIR green tea beverages, right?
Look…having the ONLY known extraction process that delivers the 60-80% bioavailability to the
$20 billion a year green tea extract market PLUS the financial partner (in South Africa’s Land
Bank) willing to fund acquisition of enough tea plantations to insure $billions and billions of
BioTea extract production is a HUGE opportunity for shareholders at the present valuation.
It’s our strongest Strong Buy recommendation…with a short term $2.50 target…and long term
$22.50 target or 23X UPSIDE from under .50 price.
2300% UPSIDE from the next $billion nutritional food company.
Final question: What are you waiting for?
BUY some shares NOW at the ground floor and DO NOT MISS this monster life changing
investment opportunity
Coverage 2 (aus dem stockhouse Forum)
Posted on May 6, 2012 by OTCJournal Editor (Extract)
"...........Please tell me you already own this one. If not, it’s probably not too late. I don’t know where the stock will open or even if it will open a lot higher than Friday’s close. However, today’s news turns the Plandai (OTC BB: PLPL) dream into a reality, and I suspect the stock is poised to rock.
Read on- only if you like making money….
Plandai (PLPL) Gets Its $13 Million; Game On
Lest you think the health food sector has not been hot of late, consider the following:
Annie’s (NYSE: BNNY); organic pasta maker- came public at $19 on March 28th- 30 days later the stock hit $44 for a 131% return
Whole Foods (NYSE: WFM): the best of breed organic grocery store chain has traded from $10 to $85 in the last 3 years- 750% return
Fresh Market (NYSE: TM): the second largest organic grocer- from $32 to $52 in the last year – 62% gain
Hain Celestial (NASDAQ: HAIN): natural and organic food manufacturer was $16 a year ago- $45 now – 182% in the last 18 months
Monster Beverage (NASDAQ: MNST): Formerly Hansen’s natural sodas- $20 to $64 in the past year- 220% in the last 15 month.
So, lest you think this sector is not smoking hot- just look at those numbers and I believe you’ll see it differently.
Identifying the up and coming small stocks in a hot sector can yield remarkable returns.
Today, before the market opened, Plandai Biotech (PLPL)- a stock I featured back on March 26th, announced a watershed event and one that I am very certain will add PLPL to the big winners list featured in the first section.
Rather than a full review of what the company does, I’ll simply reference my initial presentation if you want all the details. The March 26th edition tells you all you need to know. The stock was $.25 that day, and closed at $.28 on Friday- so there’s still plenty of upside.
The quick over view- Plandai (PLPL) is a combination agricultural/biotech technology company. The company’s founders have developed a revolutionary new technique for super charging Green Tea Extract- a food product in huge demand. Rather than license, they plan to grow tea, process extract, and sell it to major beverage companies to maximize their profit potential.
Today, before the market opened, the PLPL horses left the gate. The company has a 49 year lease on 8500 acres in prime South African tea growing country, but needed money to start growing and to build their processing plant.
Today, PLPL disclosed it had finally gotten the long awaited 100 million Rand ($13 Million US dollars) low cost loan from the South African Land Bank- an agency of the South African government.
The terms of the loan are remarkable- they pay .5% interest- yes, that’s 1/2 percent. They don’t have to make a payment for 25 months. It’s secured by the assets of the company and agricultural receivables. One subsidiary must share 15% of profits somewhere down the road.
At $.27, the stock reflected a company with interesting and exciting technology, but no money to implement its strategies.
This is a resounding endorsement of the company from the South African government. Land must be cleared, tea must be grown, and production equipment must be acquired, assembled, and producing.
Can you imagine owning this stock somewhere down the road when they start getting purchase orders from major international names in the healthy beverage industry?
You’re getting this information on PLPL before anyone. The company has filed this information with the SEC, but hasn’t put out a formal press release yet. I’m sure that’s to follow.
By the time you read this, I have no idea where the stock will be trading. If the market hasn’t jumped on it, you might be able to acquire shares at $.30 or under.
Here’s what I know. The company announced this funding from the South African government in January, and the stock ran up to $.60. Then there were complications, and it took 3 more months to close the transaction.
A return to $.60 would be a cool double from Friday’s levels. Regardless of what happens in reaction to the news in the short term, I am certain PLPL will now join the ranks of the big wins listed in the first section of today’s edition.
Much more to come on PLPL."
Source: www.otcjournal.com
Posted on May 6, 2012 by OTCJournal Editor (Extract)
"...........Please tell me you already own this one. If not, it’s probably not too late. I don’t know where the stock will open or even if it will open a lot higher than Friday’s close. However, today’s news turns the Plandai (OTC BB: PLPL) dream into a reality, and I suspect the stock is poised to rock.
Read on- only if you like making money….
Plandai (PLPL) Gets Its $13 Million; Game On
Lest you think the health food sector has not been hot of late, consider the following:
Annie’s (NYSE: BNNY); organic pasta maker- came public at $19 on March 28th- 30 days later the stock hit $44 for a 131% return
Whole Foods (NYSE: WFM): the best of breed organic grocery store chain has traded from $10 to $85 in the last 3 years- 750% return
Fresh Market (NYSE: TM): the second largest organic grocer- from $32 to $52 in the last year – 62% gain
Hain Celestial (NASDAQ: HAIN): natural and organic food manufacturer was $16 a year ago- $45 now – 182% in the last 18 months
Monster Beverage (NASDAQ: MNST): Formerly Hansen’s natural sodas- $20 to $64 in the past year- 220% in the last 15 month.
So, lest you think this sector is not smoking hot- just look at those numbers and I believe you’ll see it differently.
Identifying the up and coming small stocks in a hot sector can yield remarkable returns.
Today, before the market opened, Plandai Biotech (PLPL)- a stock I featured back on March 26th, announced a watershed event and one that I am very certain will add PLPL to the big winners list featured in the first section.
Rather than a full review of what the company does, I’ll simply reference my initial presentation if you want all the details. The March 26th edition tells you all you need to know. The stock was $.25 that day, and closed at $.28 on Friday- so there’s still plenty of upside.
The quick over view- Plandai (PLPL) is a combination agricultural/biotech technology company. The company’s founders have developed a revolutionary new technique for super charging Green Tea Extract- a food product in huge demand. Rather than license, they plan to grow tea, process extract, and sell it to major beverage companies to maximize their profit potential.
Today, before the market opened, the PLPL horses left the gate. The company has a 49 year lease on 8500 acres in prime South African tea growing country, but needed money to start growing and to build their processing plant.
Today, PLPL disclosed it had finally gotten the long awaited 100 million Rand ($13 Million US dollars) low cost loan from the South African Land Bank- an agency of the South African government.
The terms of the loan are remarkable- they pay .5% interest- yes, that’s 1/2 percent. They don’t have to make a payment for 25 months. It’s secured by the assets of the company and agricultural receivables. One subsidiary must share 15% of profits somewhere down the road.
At $.27, the stock reflected a company with interesting and exciting technology, but no money to implement its strategies.
This is a resounding endorsement of the company from the South African government. Land must be cleared, tea must be grown, and production equipment must be acquired, assembled, and producing.
Can you imagine owning this stock somewhere down the road when they start getting purchase orders from major international names in the healthy beverage industry?
You’re getting this information on PLPL before anyone. The company has filed this information with the SEC, but hasn’t put out a formal press release yet. I’m sure that’s to follow.
By the time you read this, I have no idea where the stock will be trading. If the market hasn’t jumped on it, you might be able to acquire shares at $.30 or under.
Here’s what I know. The company announced this funding from the South African government in January, and the stock ran up to $.60. Then there were complications, and it took 3 more months to close the transaction.
A return to $.60 would be a cool double from Friday’s levels. Regardless of what happens in reaction to the news in the short term, I am certain PLPL will now join the ranks of the big wins listed in the first section of today’s edition.
Much more to come on PLPL."
Source: www.otcjournal.com
Und die neueste News, welche die derzeitige Euphorie begründet:
May 7, 2012
Plandai Biotechnology, Inc. Announces the Closing of $13 Million Loan From the Land Bank of South Africa
SEATTLE, May 7, 2012 (GLOBE NEWSWIRE) -- Plandai Biotechnology, Inc., a producer of highly bioavailable plant extracts, today filed a Form 8-K with the Securities and Exchange Commission announcing that it has executed the final loan documents with the Land and Agriculture Bank of South Africa. The total amount of the loan is 100 million Rand (US $13 million).
Plandai Chairman and Chief Executive Officer, Roger Duffield, commented, "Closing this loan is a significant milestone for Plandai because it provides us with the capital necessary to move immediately into production of our highly bioavailable Green Tea extract without causing any dilution to our shareholders. Since first receiving approval for the loan from the Land Bank in December 2011, we have worked diligently to gather the necessary legal documents and ensure compliance with the loan terms. Gratefully, that patience and effort has finally paid off."
In discussing the use of proceeds from the loan, Mr. Duffield added, "We are working on a very short time table in order to reach our goal of having product market ready by early 2013. We have already contracted with our USA engineering partner, CRS Technologies Inc. Delaware, to commence the manufacture of our first hydrodynamic processing and extraction system, in order that we can begin the first commercial, bioavailable Green Tea catechin extract production by the end of the year. At the same time, we have begun work on our Senteeko tea estate to make sure there is suitable and adequate green tea crop available in the last quarter 2012. True to the purpose of the Land Bank loan, we will be employing many of the local Shamile community members to help in the farming and extraction process."
The Land and Agriculture Bank of South Africa (http://www.landbank.co.za/) is a specialist agricultural bank guided by a government mandate to provide financial services to the commercial farming sector and to agri-business and to facilitate access to finance by new entrants to agriculture from historically disadvantaged backgrounds.
May 7, 2012
Plandai Biotechnology, Inc. Announces the Closing of $13 Million Loan From the Land Bank of South Africa
SEATTLE, May 7, 2012 (GLOBE NEWSWIRE) -- Plandai Biotechnology, Inc., a producer of highly bioavailable plant extracts, today filed a Form 8-K with the Securities and Exchange Commission announcing that it has executed the final loan documents with the Land and Agriculture Bank of South Africa. The total amount of the loan is 100 million Rand (US $13 million).
Plandai Chairman and Chief Executive Officer, Roger Duffield, commented, "Closing this loan is a significant milestone for Plandai because it provides us with the capital necessary to move immediately into production of our highly bioavailable Green Tea extract without causing any dilution to our shareholders. Since first receiving approval for the loan from the Land Bank in December 2011, we have worked diligently to gather the necessary legal documents and ensure compliance with the loan terms. Gratefully, that patience and effort has finally paid off."
In discussing the use of proceeds from the loan, Mr. Duffield added, "We are working on a very short time table in order to reach our goal of having product market ready by early 2013. We have already contracted with our USA engineering partner, CRS Technologies Inc. Delaware, to commence the manufacture of our first hydrodynamic processing and extraction system, in order that we can begin the first commercial, bioavailable Green Tea catechin extract production by the end of the year. At the same time, we have begun work on our Senteeko tea estate to make sure there is suitable and adequate green tea crop available in the last quarter 2012. True to the purpose of the Land Bank loan, we will be employing many of the local Shamile community members to help in the farming and extraction process."
The Land and Agriculture Bank of South Africa (http://www.landbank.co.za/) is a specialist agricultural bank guided by a government mandate to provide financial services to the commercial farming sector and to agri-business and to facilitate access to finance by new entrants to agriculture from historically disadvantaged backgrounds.
Für die bisherigen Leser meines Threads noch das beeindruckende Interview des CEO Duffield zum Reinhören:
thestockradio.com/roger-duffield-ceo-of-plandai-biotechnology-inc-otcplpl/548
Ich habe jetzt genügend hier 'publiziert' für eventuelle Interessenten.
So gilt denn, wer will, der kann, wer nicht will der hat schon ;-)))
GLTA
thestockradio.com/roger-duffield-ceo-of-plandai-biotechnology-inc-otcplpl/548
Ich habe jetzt genügend hier 'publiziert' für eventuelle Interessenten.
So gilt denn, wer will, der kann, wer nicht will der hat schon ;-)))
GLTA
Antwort auf Beitrag Nr.: 43.171.731 von OTCBBTrader am 16.05.12 10:52:29thestockradio.com/roger-duffield-ceo-of-plandai-biotechnolog…
Antwort auf Beitrag Nr.: 43.171.731 von OTCBBTrader am 16.05.12 10:52:29Tja, Freunde, da hat die Community hier einige 100% verpasst seit meinem Beitrag vor einem Jahr. Z.Zt. finden Gewinnmitnahmen statt, aber die Stgory geht weiter. Meine absolute Überzeugung. Wir sehen uns dann wieder Mai 2014 ;-)
Antwort auf Beitrag Nr.: 44.646.665 von OTCBBTrader am 15.05.13 23:24:08900% ....nicht übel.
Antwort auf Beitrag Nr.: 44.646.665 von OTCBBTrader am 15.05.13 23:24:08900%....... nicht übel :-)
Beitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Meistdiskutiert
Wertpapier | Beiträge | |
---|---|---|
96 | ||
78 | ||
43 | ||
26 | ||
23 | ||
23 | ||
16 | ||
15 | ||
15 | ||
14 |
Wertpapier | Beiträge | |
---|---|---|
14 | ||
11 | ||
9 | ||
6 | ||
6 | ||
6 | ||
6 | ||
6 | ||
6 | ||
5 |